Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient. - Wikidata - awgldk - TriplyDB

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

http://www.wikidata.org/entity/Q44671796

about

Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection Management of HBV Infection in Liver Transplantation Patients Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant KASL clinical practice guidelines: management of chronic hepatitis B Antiviral drug resistance: mechanisms and clinical implications Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present Antiviral therapy and resistance with hepatitis B virus infection.A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B Complex dynamics of hepatitis B virus resistance to adefovir.Antiviral treatment of chronic hepatitis B virus (HBV) infections Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil.Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon.Virological response to adefovir monotherapy and the risk of adefovir resistance HBV and HCV therapy.Emerging drugs for hepatitis B.Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue Therapy Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro.Natural history of major complications in hepatitis C virus-related cirrhosis evaluated by per-rectal portal scintigraphy.Entecavir for the treatment of chronic hepatitis B.Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B.Complications in treating chronic hepatitis B in patients with HIV.Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues Review article: hepatitis B and liver transplantation.Antiviral therapies: focus on hepatitis B reverse transcriptase Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy Recurrence of diseases following orthotopic liver transplantation.Treatment options for chronic hepatitis B and C infection in children.Prevention of hepatitis B virus recurrence after liver transplantation.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.Management of chronic hepatitis B: consensus guidelines Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

P2860

Q24187530-F6558C8B-24E3-492D-AE0F-01264E3FE3E1 Q24529103-7FDC4100-0A12-40A2-9211-C175F73D1F4F Q25256648-E5A6575B-0A5B-4292-BADC-3763EA9CE922 Q26752475-3F36CFAB-C149-4AFF-9BA5-E919E2B8ADAD Q28282376-3B0EEADC-B72C-4984-96B2-1B37DD9F7850 Q33206221-3E529D45-B6C4-4C2C-AC7D-9ABAB132FA2D Q33233245-FDD9D4FA-8F8F-4845-92E9-BC9674969F5E Q33267067-B8FE1201-E27A-449B-85A7-1A095AFEB6EC Q33787531-A208F331-949B-42D5-9A35-DB6754690449 Q33852071-CAA203D3-7CA6-4A9E-B836-07CC3A6787A3 Q33883722-880397C9-FA5B-4B72-8101-5BEBE7C70E28 Q33918275-5DDCF549-EC79-4223-B380-FE2AC98F9B58 Q34208672-B10DBD5C-AC14-4853-B87F-DDE66191E936 Q34223779-0934E027-0D90-46F2-9795-634FDA182D04 Q34362568-9AED6F28-CB01-4F02-BE53-9F091C597F92 Q34364620-9C625F20-CEB8-4414-804E-6F2050F54205 Q34719476-F255925B-9A0D-4B10-BDD0-E3CD25F5EFD6 Q35050618-D668B687-CAC4-4ECC-BDC6-A84DC5B96DCD Q35185125-65A47EE2-C80E-4556-A7D6-5F1D10A30258 Q35259824-DD0C653E-DCE9-426B-85B5-7BD6D9C9EDD3 Q35359369-9EBD3663-9709-40B5-9FCC-9305761EBE1F Q35635522-9CF73E09-9DEA-4F0F-B026-78A3C0D33DA8 Q35721334-75D6209C-CCBC-4B86-92FE-BCF237257E66 Q35858997-BD51B06D-0F65-45EA-9BBC-CBEDB8765E56 Q35964745-8039356A-C9D2-470D-AFCE-56851CB8E6C2 Q36007344-2D00427E-9951-4B92-8958-9C0402E824CD Q36153966-7D4A9124-E86B-4172-BF04-BF9EA13AC6B7 Q36304057-8FC9878D-D114-43F2-953E-42DB06C9B6F1 Q36327100-2B6006C7-BE4A-4B61-B56E-F3970EC949A1 Q36442537-48A27061-AF7F-4081-AF6A-440F5EED5663 Q36447557-29DAF66D-10CC-4046-8066-EA77BAE4FDB3 Q36467514-908C5C0F-12FA-4694-BA01-2F53C32899D3 Q36502057-C4CC4333-35E6-46A8-9FFB-6C8FF6A69AAA Q36505790-DB22E6FE-3087-4E0D-95E5-07868DF6B08B Q36607394-D0B28982-4D06-434F-9A9E-52A2F08F2F99 Q36652077-DBB4A51A-EE24-4EC0-89CD-A82F1DA1F991 Q36698116-C2ED6049-D1AC-402E-BCB7-F0D8BF0CF8EC Q36849343-C0695E9B-1E58-46CD-97D7-8560263C03EE Q36954038-B4AC4B40-2A78-4BF1-832A-A4C4757116EC Q36980718-573FFFA6-AD05-40C8-B4AA-76DF7BD18419

P2860

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient.

http://www.wikidata.org/entity/Q44671796

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Selection of a hepatitis B vir ...... liver transplantation patient.

@en

Selection of a hepatitis B vir ...... liver transplantation patient.

@nl

type

label

Selection of a hepatitis B vir ...... liver transplantation patient.

@en

Selection of a hepatitis B vir ...... liver transplantation patient.

@nl

prefLabel

Selection of a hepatitis B vir ...... liver transplantation patient.

@en

Selection of a hepatitis B vir ...... liver transplantation patient.

@nl

P1433

Q44671796-039E0466-F1CC-4826-BE5A-447CD27304FE

P1476

Q44671796-170D42DA-6994-4899-89C9-BDFBBC300E69

P2093

Q44671796-10795920-CA89-4453-A870-73EE6E512528

Q44671796-2D053112-5C2C-42DE-B8DE-26686EB3577E

Q44671796-7941BF33-2FB9-4951-A533-1BD474925D06

Q44671796-9C44AA91-BDE8-4A72-90A0-959154530508

Q44671796-A16ECAB9-5BCD-4F5E-B2A7-7FE14F2FA03D

Q44671796-AD53ADDD-E584-4CD7-9130-D2B56CB6768F

Q44671796-D1E90A04-9DAA-470A-A424-3D9E6287FAFF

Q44671796-E9D3878C-F407-41A0-96E1-9B7B445DFA1C

Q44671796-EE94F755-FB27-460B-BF80-CDE20987E785

Q44671796-EFF91342-E16F-43A7-A6BD-8DE445553EC8

P304

Q44671796-4599FEAC-822D-43BD-AAF4-4DAA825C39FE

P31

Q44671796-FB11750F-3E62-4BFE-AE5B-75C9036FA028

P356

Q44671796-3DFA6C7B-A2A1-4F97-B92A-E5C65CF87457

P433

Q44671796-DDB0BECC-0138-421D-BDD0-168B53E485E2

P478

Q44671796-C44E127E-83FA-4F61-9AF2-AAB742D85DD7

P50

Q44671796-AA2ACA4B-B87A-4B29-8FF5-F117DFEA2B18

P577

Q44671796-4DD44AAD-6661-4103-B4AA-477898A33AA3

P698

Q44671796-A16D9475-B517-4741-8851-100096CA7BEE

P921

Q44671796-7AB01BDC-BB97-4818-9799-6EA07CA258AA

Q44671796-AAEB7275-19EB-41A7-B7C8-D38300594119

P356

J.JHEP.2003.09.022

P1433

Journal of Hepatology

P1476

Selection of a hepatitis B vir ...... liver transplantation patient

@en

P2093

Bettina Werle

http://www.w3.org/2001/XMLSchema#string

Carol L Brosgart

http://www.w3.org/2001/XMLSchema#string

Christian Trépo

http://www.w3.org/2001/XMLSchema#string

Christopher Westland

http://www.w3.org/2001/XMLSchema#string

Craig S Gibbs

http://www.w3.org/2001/XMLSchema#string

David Durantel

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Villeneuve

http://www.w3.org/2001/XMLSchema#string

Parviz Parvaz

http://www.w3.org/2001/XMLSchema#string

Sandra Durantel

http://www.w3.org/2001/XMLSchema#string

Shelly Xiong

http://www.w3.org/2001/XMLSchema#string

P304

1085-1089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2003.09.022

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14642631

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation